- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01501552
Trial Testing the Effect of Strategies on Performance of Brief Intervention Programmes for Harmful Alcohol Consumption (ODHIN_RCT)
September 5, 2016 updated by: Antoni Gual, Fundacion Clinic per a la Recerca Biomédica
Randomised Controlled Trial Testing the Incremental Effect of Strategies That Raise Awareness, Acceptance and Performance of Identification and Brief Intervention Programmes for Harmful Alcohol Consumption in Primary Health Care
The overall objective is to study if training and support, financial reimbursement and referral to an internet based brief intervention programme, singly or in combination, may increase implementation of evidence based methods of identification and brief intervention for excessive alcohol consumption in routine primary health care.
Study Overview
Status
Completed
Conditions
Detailed Description
The study will be a stepped cluster RCT in 5 countries and the endpoint of the study is the number of interventions delivered during a certain time period. More specifically, the RCT will examine:
- The effect of Continuous Medical Education (CME) to PHC providers
- The effect of financial reimbursement to PHC providers as a pay-for-performance of brief alcohol interventions
- Whether an alternative internet based method of delivering brief intervention can increase the proportion of patients reached
- If one implementation strategy will give an added value to one already enforced.
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Maastricht, Netherlands, 229 ER
- Maastricht University
-
Nijmegen, Netherlands, 6525 HP
- Stichting Katholieke Universiteit
-
-
-
-
-
Szczecin, Poland, 70 204
- Pomorski Uniwersytet Medyczny w Szczecinie
-
Warsaw, Poland, 01 458
- Panstwowa Agencja Rozwiazywania Problemow Alkoholowych
-
-
-
-
Catalonia
-
Barcelona, Catalonia, Spain, 08005
- Departament de Salut de la Generalitat de Catalunya
-
-
-
-
-
Goeteborg, Sweden, PO Box 100, SE-405 30
- Goeteborgs Universitet
-
Linköping, Sweden, SE-581 83
- Linköping University
-
-
-
-
England
-
London, England, United Kingdom, SE1 8WA
- King's College London
-
London, England, United Kingdom, WC1E 6HJ
- University College, London
-
Newcastle Upon-Tyne, England, United Kingdom, NE1 7RU
- University of Newcastle Upon-Tyne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary Health Care Units (PHCU) of approximate size of 5.000-20.000 registered patients
- Primary Health Care Units (PHCU) located in Spain, Poland, Sweden, England or The Netherlands
- Providers must be physicians or nurses
Exclusion Criteria:
- Primary Health Care Units with less than 5.000 registered patients or over 20.000 registered patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Treatment as usual
In the no-intervention treatment as usual group, a package, containing a summary card of the national guideline recommendation, will be delivered to each provider unit without demonstration.
In Poland, the summary card will be adapted from the PHEPA guidelines (ref) for the purposes of this trial.
The treatment as usual group will be requested to screen and offer person-to-person SBI at the PHCU.
|
|
Experimental: Training & support (T&S)
The T&S only group will be offered two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
The telephone call will be offered to one of the GPs ('leader').
Depending on the needs of the PHCU, one additional face to face training (1 to 2 hours) may be offered.
The time interval between meetings will be on average 2 weeks.
The training sessions will address improving knowledge, skills, attitudes, and perceived barriers and facilitators by combining theory and practice-based training.
|
Two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
The telephone call will be offered to one of the GPs ('leader').
Depending on the needs of the PHCU, one additional face to face training (1 to 2 hours) may be offered.
The time interval between meetings will be on average 2 weeks.
The training sessions will address improving knowledge, skills, attitudes, and perceived barriers and facilitators by combining theory and practice-based training.
|
Experimental: Financial incentive
The financial incentive only group will receive a financial incentive depending on their screening and brief intervention activities.
They will be paid for the performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
|
Groups will receive a financial incentive depending on their screening and brief intervention activities.
They will be paid for the performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
|
Experimental: E-SBI
The e-SBI (online screening and brief intervention)only group are expected to refer identified at-risk patients to an approved e-SBI programme, which will be either country specific (where these exist) or based on the WHO e-SBI programme (Poland).
|
Referring identified at-risk patients to an approved e-SBI programme, which will be either country specific (where these exist) or based on the WHO e-SBI programme (Poland).
|
Experimental: T&S and financial incentive
The T&S and financial incentive group will be offered two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
Also, they will receive a financial incentive depending on their screening and brief intervention activities.
They will be paid for the performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
|
Two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
The telephone call will be offered to one of the GPs ('leader').
Depending on the needs of the PHCU, one additional face to face training (1 to 2 hours) may be offered.
The time interval between meetings will be on average 2 weeks.
The training sessions will address improving knowledge, skills, attitudes, and perceived barriers and facilitators by combining theory and practice-based training.
Groups will receive a financial incentive depending on their screening and brief intervention activities.
They will be paid for the performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
|
Experimental: T&S and e-SBI
The T&S and e-SBI group will be offered two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
The telephone call was offered to one of the GPs ('leader').
Depending on the needs of the PHCU, one additional face to face training (1 to 2 hours) was offered.
Also this group is expected to refer identified at-risk patients to an approved e-SBI (online screening and brief intervention) programme, which will either be country specific (where these exist) or based on the WHO e-SBI programme (Poland).
|
Two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
The telephone call will be offered to one of the GPs ('leader').
Depending on the needs of the PHCU, one additional face to face training (1 to 2 hours) may be offered.
The time interval between meetings will be on average 2 weeks.
The training sessions will address improving knowledge, skills, attitudes, and perceived barriers and facilitators by combining theory and practice-based training.
Referring identified at-risk patients to an approved e-SBI programme, which will be either country specific (where these exist) or based on the WHO e-SBI programme (Poland).
|
Experimental: Financial incentive and e-SBI
The financial incentive and e-SBI (online screening and brief intervention) group will be paid for screening and referral performance instead of actual delivery of e-SBI by themselves as in line with the e-SBI only group, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
|
Groups will receive a financial incentive depending on their screening and brief intervention activities.
They will be paid for the performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
Referring identified at-risk patients to an approved e-SBI programme, which will be either country specific (where these exist) or based on the WHO e-SBI programme (Poland).
|
Experimental: T&S, financial incentive and e-SBI
The T&S, financial incentive and e-SBI (online screening and brief intervention) group will be offered two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
The telephone call will be offered to one of the GPs ('leader').
Also, they are expected to offer screening at the PHCU and to refer screen positive patients to e-SBI programmes.
Additionally, they will be paid for screening and referral performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
|
Two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes.
The telephone call will be offered to one of the GPs ('leader').
Depending on the needs of the PHCU, one additional face to face training (1 to 2 hours) may be offered.
The time interval between meetings will be on average 2 weeks.
The training sessions will address improving knowledge, skills, attitudes, and perceived barriers and facilitators by combining theory and practice-based training.
Groups will receive a financial incentive depending on their screening and brief intervention activities.
They will be paid for the performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.
Referring identified at-risk patients to an approved e-SBI programme, which will be either country specific (where these exist) or based on the WHO e-SBI programme (Poland).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of screening tests carried out in primary health care settings to detect excessive alcohol consumption care
Time Frame: 5 months
|
Screening rates will be calculated at five time points: during a four week period during the third month before the start of the study (baseline measurement), in three consecutive four week blocks during the twelve week intervention period (intervention measurement) and during a four week block during the sixth month after the end of the intervention period (follow-up measurement).
|
5 months
|
Number of brief interventions for excessive alcohol consumption delivered in primary health care settings
Time Frame: 5 months
|
Brief intervention rates will be calculated at five time points: during a four week period during the third month before the start of the study (baseline measurement), in three consecutive four week blocks during the twelve week intervention period (intervention measurement) and during a four week block during the sixth month after the end of the intervention period (follow-up measurement).
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of role security of primary health care providers measured by their answers to the SAAPPQ instrument
Time Frame: 3 months
|
Role security of the primary health care providers will be measured through their responses to the SAAPPQ (a validated instrument based on factor analysis (Anderson & Clement 1987) of the original alcohol and alcohol problems perception questionnaire developed and validated by Cartwright (1980))at three time points: baseline, end of intervention period, and follow-up.
|
3 months
|
Level of therapeutic commitment of primary health care providers measured by their answers to the SAAPPQ instrument
Time Frame: 3 months
|
Therapeutic commitment of the primary health care providers will be measured through their responses to the SAAPPQ (a validated instrument based on factor analysis (Anderson & Clement 1987) of the original alcohol and alcohol problems perception questionnaire developed and validated by Cartwright (1980))at three time points: baseline, end of intervention period, and follow-up.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Preben - Bendtsen, MD, Linkoeping University
- Principal Investigator: Fredrik - Spak, MD, Göteborg University
- Principal Investigator: Peter - Anderson, MD, Maastricht University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Angus C, Li J, Romero-Rodriguez E, Anderson P, Parrott S, Brennan A. Cost-effectiveness of strategies to improve delivery of brief interventions for heavy drinking in primary care: results from the ODHIN trial. Eur J Public Health. 2019 Apr 1;29(2):219-225. doi: 10.1093/eurpub/cky181.
- Anderson P, Kloda K, Kaner E, Reynolds J, Bendtsen P, Pelgrum-Keurhorst MN, Segura L, Wojnar M, Mierzecki A, Deluca P, Newbury-Birch D, Parkinson K, Okulicz-Kozaryn K, Drummond C, Laurant MGH, Gual A. Impact of practice, provider and patient characteristics on delivering screening and brief advice for heavy drinking in primary healthcare: Secondary analyses of data from the ODHIN five-country cluster randomized factorial trial. Eur J Gen Pract. 2017 Dec;23(1):241-245. doi: 10.1080/13814788.2017.1374365.
- Anderson P, Coulton S, Kaner E, Bendtsen P, Kloda K, Reynolds J, Segura L, Wojnar M, Mierzecki A, Deluca P, Newbury-Birch D, Parkinson K, Okulicz-Kozaryn K, Drummond C, Gual A. Delivery of Brief Interventions for Heavy Drinking in Primary Care: Outcomes of the ODHIN 5-Country Cluster Randomized Trial. Ann Fam Med. 2017 Jul;15(4):335-340. doi: 10.1370/afm.2051.
- Keurhorst M, Anderson P, Heinen M, Bendtsen P, Baena B, Brzozka K, Colom J, Deluca P, Drummond C, Kaner E, Kloda K, Mierzecki A, Newbury-Birch D, Okulicz-Kozaryn K, Palacio-Vieira J, Parkinson K, Reynolds J, Ronda G, Segura L, Slodownik L, Spak F, van Steenkiste B, Wallace P, Wolstenholme A, Wojnar M, Gual A, Laurant M, Wensing M. Impact of primary healthcare providers' initial role security and therapeutic commitment on implementing brief interventions in managing risky alcohol consumption: a cluster randomised factorial trial. Implement Sci. 2016 Jul 16;11:96. doi: 10.1186/s13012-016-0468-5.
- Bendtsen P, Mussener U, Karlsson N, Lopez-Pelayo H, Palacio-Vieira J, Colom J, Gual A, Reynolds J, Wallace P, Segura L, Anderson P. Implementing referral to an electronic alcohol brief advice website in primary healthcare: results from the ODHIN implementation trial. BMJ Open. 2016 Jun 16;6(6):e010271. doi: 10.1136/bmjopen-2015-010271.
- Keurhorst M, Heinen M, Colom J, Linderoth C, Mussener U, Okulicz-Kozaryn K, Palacio-Vieira J, Segura L, Silfversparre F, Slodownik L, Sorribes E, Laurant M, Wensing M. Strategies in primary healthcare to implement early identification of risky alcohol consumption: why do they work or not? A qualitative evaluation of the ODHIN study. BMC Fam Pract. 2016 Jun 7;17:70. doi: 10.1186/s12875-016-0461-8.
- Anderson P, Bendtsen P, Spak F, Reynolds J, Drummond C, Segura L, Keurhorst MN, Palacio-Vieira J, Wojnar M, Parkinson K, Colom J, Kloda K, Deluca P, Baena B, Newbury-Birch D, Wallace P, Heinen M, Wolstenholme A, van Steenkiste B, Mierzecki A, Okulicz-Kozaryn K, Ronda G, Kaner E, Laurant MG, Coulton S, Gual T. Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster randomized factorial trial. Addiction. 2016 Nov;111(11):1935-1945. doi: 10.1111/add.13476. Epub 2016 Jul 25.
- Keurhorst MN, Anderson P, Spak F, Bendtsen P, Segura L, Colom J, Reynolds J, Drummond C, Deluca P, van Steenkiste B, Mierzecki A, Kloda K, Wallace P, Newbury-Birch D, Kaner E, Gual T, Laurant MG. Implementing training and support, financial reimbursement, and referral to an internet-based brief advice program to improve the early identification of hazardous and harmful alcohol consumption in primary care (ODHIN): study protocol for a cluster randomized factorial trial. Implement Sci. 2013 Jan 24;8:11. doi: 10.1186/1748-5908-8-11.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
December 16, 2011
First Submitted That Met QC Criteria
December 27, 2011
First Posted (Estimate)
December 29, 2011
Study Record Updates
Last Update Posted (Estimate)
September 7, 2016
Last Update Submitted That Met QC Criteria
September 5, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ECGA259268
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcoholism
-
Yale UniversityCompletedFamilial Alcoholism VulnerabilityUnited States
-
Yonsei UniversityTerminated
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingFamilial Alcoholism VulnerabilityUnited States
-
University of Southern DenmarkActive, not recruitingGeneral Practice | Alcohol Abuse Alcoholism | Screening and Brief InterventionDenmark
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedEffects of Family History of Alcoholism and Sex on Alcohol AnalgesiaUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcoholic Liver Disease | Alcoholism,United States
-
Khoo Teck Puat HospitalNot yet recruitingEmergencies | Alcohol Use Disorder | Alcoholism and Alcohol Abuse
-
VA Office of Research and DevelopmentRecruiting
-
University of New MexicoNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...TerminatedAlcoholismUnited States
-
Emory UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)TerminatedAlcoholismUnited States
Clinical Trials on Training and support (T&S)
-
Heinen und Löwenstein GmbH & Co. KGLöwenstein Medical TechnologyUnknownSleep Apnea, Obstructive | Sleep Apnea, CentralGermany
-
Northwell HealthRecruitingHypercapnic Respiratory FailureUnited States
-
McGill UniversityCHU de Quebec-Universite Laval; Centre de recherche du Centre hospitalier universitaire... and other collaboratorsNot yet recruitingImmune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic Disease | Glucose Metabolism Disorders (Including Diabetes Mellitus)Canada
-
Philips RespironicsTerminatedSleep Disordered BreathingUnited States
-
University of California, Los AngelesAll India Institute of Medical Sciences, New Delhi; University of California... and other collaboratorsCompleted
-
University of ManitobaUnknown
-
Poitiers University HospitalCompletedWeaning From Mechanical Ventilation | ExtubationFrance
-
Hitit UniversityAnkara Ataturk Sanatorium Training and Research HospitalRecruitingVideo-assisted Thoracoscopic SurgeryTurkey
-
Cristina GenzorHospital Miguel ServetUnknownCardiopulmonary Arrest With Successful Resuscitation | Child, OnlySpain
-
University of the Incarnate Word59th Medical Wing; United States Naval Medical Center, San Diego; Madigan Army... and other collaboratorsCompletedPreterm Birth | Maternal | Infant, Low Birth Weight | Anxiety Fear | Prenatal DepressionUnited States